Ideal Implant Aims For Saline Breast Implant With Natural-Tissue Feel
This article was originally published in The Gray Sheet
Start-up firm Ideal Implant aims to compete in the lucrative breast implant market with a novel design offering the safety of saline and the natural feel of silicone gel, according to founder and president Robert Hamas.
You may also be interested in...
Due to lower-than-expected follow-up rates for Allergan and Johnson & Johnson/Mentor’s silicone-gel-filled breast implant post-approval studies, FDA advisory panel members last week called for a national registry to better document long-term outcomes and complications.
Data show Opdivo/Cabometyx combo bests Sutent for overall and progression-free survival and response endpoints in first-line RCC. Exelixis CEO says comparison to Sutent is standard control and allows better comparison to other combo regimens.
ES: Public Company Edition: Fifty biopharma companies launched initial public offerings in the US last year and there have been 52 so far in 2020, including Metacrine, Dyne, Athira and COMPASS.